BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13(19): 2649-2654 [PMID: 17569132 DOI: 10.3748/wjg.v13.i19.2649]
URL: https://www.wjgnet.com/1007-9327/full/v13/i19/2649.htm
Number Citing Articles
1
A E Obaro, S M Ryan. Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearancesUltrasound 2015; 23(2): 116 doi: 10.1177/1742271X15575805
2
Yang Shin Park, Chang Hee Lee, Jeong Woo Kim, Sora Shin, Cheol Min Park. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?World Journal of Gastroenterology 2016; 22(1): 284-299 doi: 10.3748/wjg.v22.i1.284
3
Luigi Grazioli, Maria Pia Bondioni, Hiroki Haradome, Utaroh Motosugi, Rita Tinti, Barbara Frittoli, Sebastiana Gambarini, Francesco Donato, Stefano Colagrande. Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential DiagnosisRadiology 2012; 262(2): 520 doi: 10.1148/radiol.11101742
4
Paulo Herman, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Vagner Birk Jeismann, Fabricio Ferreira Coelho. Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons’ PerspectiveJournal of Gastrointestinal Surgery 2021; 25(6): 1494 doi: 10.1007/s11605-020-04724-1
5
Taofic Mounajjed. Hepatocellular Adenoma and Focal Nodular HyperplasiaClinical Liver Disease 2021; 17(4): 244 doi: 10.1002/cld.1069
6
Timo Alexander Auer, Thula Walter-Rittel, Dominik Geisel, Wenzel Schöning, Moritz Schmelzle, Tobias Müller, Bruno Sinn, Timm Denecke, Bernd Hamm, Uli Fehrenbach. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRIBMC Medical Imaging 2021; 21(1) doi: 10.1186/s12880-021-00552-0
7
Jimin Xu, Sebastiano Filetti, Jerome M. Hershman. Expression of Hepatocyte Nuclear Factor-1α mRNA in Human Anaplastic Thyroid Cancer Cell Lines and TumorsThyroid 2008; 18(5): 533 doi: 10.1089/thy.2007.0312
8
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2010; : 181 doi: 10.1016/B978-0-7020-3410-7.00017-4
9
Roger Klein Moreira, Kay Washington. Gastrointestinal and Liver Pathology2012; : 626 doi: 10.1016/B978-1-4377-0925-4.00029-8
10
D. -C. Valla. Post’U FMC-HGE2009; : 138 doi: 10.1007/978-2-287-99247-6_18
11
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, Aileen Wee. MacSween's Pathology of the Liver2024; : 842 doi: 10.1016/B978-0-7020-8228-3.00013-2
12
Kwun Wah Wen, Sanjay Kakar. Hepatic Precancerous Lesions and Early Hepatocellular CarcinomaGastroenterology Clinics of North America 2024; 53(1): 109 doi: 10.1016/j.gtc.2023.11.005
13
V.J. Desmet, Juan Rosai. Rosai and Ackerman's Surgical Pathology2011; : 857 doi: 10.1016/B978-0-323-06969-4.00001-5
14
Tatsuaki Sumiyoshi, Michihisa Moriguchi, Hideyuki Kanemoto, Kouiku Asakura, Keiko Sasaki, Teiichi Sugiura, Takashi Mizuno, Katsuhiko Uesaka. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a caseSurgery Today 2012; 42(2): 200 doi: 10.1007/s00595-011-0067-7
15
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognosticationChinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
16
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, Aileen Wee. Macsween's Pathology of the Liver2018; : 780 doi: 10.1016/B978-0-7020-6697-9.00013-3
17
Inge J.S.M.L. Vanhooymissen, Maarten G. Thomeer, Loes M.M. Braun, Bibiche Gest, Sebastiaan van Koeverden, Francois E. Willemssen, Myriam Hunink, Robert A. De Man, Jan N. Ijzermans, Roy S. Dwarkasing. Intrapatient Comparison of the Hepatobiliary Phase of Gd‐BOPTA and Gd‐EOB‐DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular HyperplasiaJournal of Magnetic Resonance Imaging 2019; 49(3): 700 doi: 10.1002/jmri.26227
18
Oren Shaked, Evan S. Siegelman, Kim Olthoff, K. Rajender Reddy. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the LiverClinical Gastroenterology and Hepatology 2011; 9(7): 547 doi: 10.1016/j.cgh.2011.03.007
19
Jianxin Yang, Xue Bai, Guiqin Liu, Xiangyang Li. A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolismDrug Metabolism Reviews 2022; 54(4): 361 doi: 10.1080/03602532.2022.2103146
20
Jay H. Lefkowitch. Recent developments in liver pathologyHuman Pathology 2009; 40(4): 445 doi: 10.1016/j.humpath.2008.12.014
21
Jason You, Hushan Yang, Yinzhi Lai, Lindsay Simon, Jen Au, Ashlie L. Burkart. Erratum to ARID2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implicationsHuman Pathology 2015; 46(7): 1068 doi: 10.1016/j.humpath.2015.05.005
22
Yongjun Liu, Yao-Zhong Liu, Lifu Sun, Yoh Zen, Chie Inomoto, Matthew M. Yeh. Subtyping of hepatocellular adenoma: a machine learning-based approachVirchows Archiv 2022; 481(1): 49 doi: 10.1007/s00428-022-03311-w
23
Ulrike A. Köhler, Friederike Böhm, Frank Rolfs, Michèle Egger, Thorsten Hornemann, Manolis Pasparakis, Achim Weber, Sabine Werner. NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenomaJournal of Hepatology 2016; 64(1): 94 doi: 10.1016/j.jhep.2015.08.033
24
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 443 doi: 10.1007/978-3-319-26956-6_24
25
Taofic Mounajjed, Saba Yasir, Patrice A Aleff, Michael S Torbenson. Pigmented hepatocellular adenomas have a high risk of atypia and malignancyModern Pathology 2015; 28(9): 1265 doi: 10.1038/modpathol.2015.83
26
Marion Roux, Frederic Pigneur, Laurence Baranes, Julien Calderaro, Mélanie Chiaradia, Thomas Decaens, Sandrine Kastahian, Anaïs Charles-Nelson, Lambros Tselikas, Charlotte Costentin, Alexis Laurent, Daniel Azoulay, Ariane Mallat, Alain Rahmouni, Alain Luciani. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Abdominal Radiology 2018; 43(7): 1670 doi: 10.1007/s00261-017-1377-z
27
Nafis Shafizadeh, Sanjay Kakar. Diagnosis of Well-differentiated Hepatocellular LesionsAdvances in Anatomic Pathology 2011; 18(6): 438 doi: 10.1097/PAP.0b013e318234abb4
28
Timm Denecke, Ingo G. Steffen, Sheela Agarwal, Daniel Seehofer, Thomas Kröncke, Enrique Lopez Hänninen, Incken-Birthe Kramme, Peter Neuhaus, Sanjay Saini, Bernd Hamm, Christian Grieser. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRIEuropean Radiology 2012; 22(8): 1769 doi: 10.1007/s00330-012-2422-5
29
Dimitrios Dimitroulis, Panagiotis Lainas, Petros Charalampoudis, Theodore Karatzas, Ioanna Delladetsima, Stratigoula Sakellariou, Nikolaos Karidis, Gregory Kouraklis. Co-existence of hepatocellular adenoma and focal nodular hyperplasia in a young femaleWorld Journal of Hepatology 2012; 4(11): 314-318 doi: 10.4254/wjh.v4.i11.314
30
Paulo Herman, Fabricio Ferreira Coelho, Marcos Vinicius Perini, Renato Micelli Lupinacci, Luiz Augusto Carneiro D'Albuquerque, Ivan Cecconello. Hepatocellular adenoma: an excellent indication for laparoscopic liver resectionHPB 2012; 14(6): 390 doi: 10.1111/j.1477-2574.2012.00463.x
31
Melissa E. Kahn, Samuel French, Hanlin L. Wang. Hepatocellular AdenomaPathology Case Reviews 2009; 14(1): 13 doi: 10.1097/PCR.0b013e31819c4956
32
Elaine S. Chan, Matthew M. Yeh. The Use of Immunohistochemistry in Liver TumorsClinics in Liver Disease 2010; 14(4): 687 doi: 10.1016/j.cld.2010.10.001
33
Jan H.M.B. Stoot, Robert J.S. Coelen, Mechteld C. De Jong, Cornelis H.C. Dejong. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma casesHPB 2010; 12(8): 509 doi: 10.1111/j.1477-2574.2010.00222.x
34
Dirk Schmidt-Arras, Miryam Müller, Marija Stevanovic, Silke Horn, Antje Schütt, Juri Bergmann, Ruven Wilkens, Annett Lickert, Stefan Rose-John. Oncogenic deletion mutants of gp130 signal from intracellular compartmentsJournal of Cell Science 2013;  doi: 10.1242/jcs.130294
35
Aurélie Beaufrère, Valérie Paradis. Hepatocellular adenomas: review of pathological and molecular featuresHuman Pathology 2021; 112: 128 doi: 10.1016/j.humpath.2020.11.016
36
Hengqi (Betty) Zheng, Laura S. Finn, Karen F. Murray. Pediatric Gastrointestinal and Liver Disease2021; : 527 doi: 10.1016/B978-0-323-67293-1.00048-7
37
Elia Pulvirenti, Adriana Toro, Isidoro Di Carlo. An update on indications for treatment of solid hepatic neoplasms in noncirrhotic liverFuture Oncology 2010; 6(8): 1243 doi: 10.2217/fon.10.85
38
Luigi Grazioli, Lucio Olivetti, Giancarlo Mazza, Maria Pia Bondioni. MR Imaging of Hepatocellular Adenomas and Differential Diagnosis DilemmaInternational Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/374170
39
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2016; : 193 doi: 10.1016/B978-0-7020-5548-5.00011-6
40
Jean–Charles Nault, Paulette Bioulac–Sage, Jessica Zucman–Rossi. Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical CareGastroenterology 2013; 144(5): 888 doi: 10.1053/j.gastro.2013.02.032
41
Christopher O C Bellamy, R Scott Maxwell, Sandrine Prost, Ijeoma A Azodo, James J Powell, Jonathan R Manning. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centreHistopathology 2013; 62(3): 431 doi: 10.1111/his.12011
42
Thomas Longerich, Volker Endris, Olaf Neumann, Eugen Rempel, Martina Kirchner, Zahra Abadi, Sebastian Uhrig, Mark Kriegsmann, Karl Heinz Weiss, Kai Breuhahn, Arianeb Mehrabi, Tim Frederik Weber, Ludwig Wilkens, Beate K Straub, Andreas Rosenwald, Falko Schulze, Benedikt Brors, Stefan Froehling, Rossella Pellegrino, Jan Budczies, Peter Schirmacher, Albrecht Stenzinger. RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumoursGut 2019; 68(7): 1287 doi: 10.1136/gutjnl-2018-317632
43
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_24-1
44
Julien Calderaro, Jessica Zucman‐Rossi. Schiff's Diseases of the Liver2017; : 947 doi: 10.1002/9781119251316.ch35
45
Matthanja Bieze, Roelof J. Bennink, Youssef El-Massoudi, Saffire S.K.S. Phoa, Joanne Verheij, Ulrich Beuers, Thomas M. van Gulik. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenomaNuclear Medicine Communications 2013; 34(2): 146 doi: 10.1097/MNM.0b013e32835afe62
46
Jianhong Li, Zongming Eric Chen, Fan Lin. Handbook of Practical Immunohistochemistry2022; : 661 doi: 10.1007/978-3-030-83328-2_27
47
Zongming E. Chen, Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry2015; : 503 doi: 10.1007/978-1-4939-1578-1_26
48
Geunyoung Jung, Yongjun Liu. Hepatocellular Adenoma: A Case Report, Current Updates on Subtyping, and Diagnostic PitfallsAJSP: Reviews and Reports 2022; 27(6): 228 doi: 10.1097/PCR.0000000000000527
49
Francesco Cetta. Benign Tumors of the Liver2015; : 13 doi: 10.1007/978-3-319-12985-3_2
50
Tetsuyuki Takahashi, Takeshi Nishida, Hayato Baba, Hideki Hatta, Johji Imura, Mitsuko Sutoh, Syunji Toyohara, Ryoji Hokao, Syunsuke Watanabe, Hirohisa Ogawa, Hisanori Uehara, Koichi Tsuneyama. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse)Molecular and Clinical Oncology 2016; 5(2): 267 doi: 10.3892/mco.2016.924
51
Anne-Frédérique Manichon, Brigitte Bancel, Marion Durieux-Millon, Christian Ducerf, Jean-Yves Mabrut, Marie-Annick Lepogam, Agnès Rode. Hepatocellular Adenoma: Evaluation with Contrast-Enhanced Ultrasound and MRI and Correlation with Pathologic and Phenotypic Classification in 26 LesionsHPB Surgery 2012; 2012: 1 doi: 10.1155/2012/418745
52
Madhavi Patnana, Christine O. Menias, Perry J. Pickhardt, Mohamed Elshikh, Sanaz Javadi, Ayman Gaballah, Akram M. Shaaban, Brinda Rao Korivi, Naveen Garg, Khaled M. Elsayes. Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CTAmerican Journal of Roentgenology 2018; 211(1): 76 doi: 10.2214/AJR.18.19704
53
Matthanja Bieze, Paulette Bioulac-Sage, Joanne Verheij, Charles Balabaud, Christophe Laurent, Thomas M. van Gulik. Hepatocellular Adenomas Associated with Hepatic Granulomas: Experience in Five CasesCase Reports in Gastroenterology 2012; 6(3): 677 doi: 10.1159/000343434
54
Maneesh Khanna, Subramaniyan Ramanathan, Najla Fasih, Nicola Schieda, Vivek Virmani, Matthew D. F. McInnes. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenomaInsights into Imaging 2015; 6(3): 347 doi: 10.1007/s13244-015-0399-8
55
Gillian Hale, Xinxin Liu, Junjie Hu, Zhong Xu, Li Che, David Solomon, Christos Tsokos, Nafis Shafizadeh, Xin Chen, Ryan Gill, Sanjay Kakar. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinomaModern Pathology 2016; 29(11): 1370 doi: 10.1038/modpathol.2016.122
56
Janardhana Ponnatapura, Ania Kielar, Lauren M.B. Burke, Mark E. Lockhart, Abdul-Rahman Abualruz, Rafel Tappouni, Neeraj Lalwani. Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyondMagnetic Resonance Imaging 2019; 60: 110 doi: 10.1016/j.mri.2019.04.010
57
Timo Alexander Auer, Uli Fehrenbach, Christian Grieser, Tobias Penzkofer, Dominik Geisel, Moritz Schmelzle, Tobias Müller, Hendrik Bläker, Daniel Seehofer, Timm Denecke. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?European Radiology 2020; 30(6): 3497 doi: 10.1007/s00330-020-06726-8
58
Sandra E. Fischer. Hepatocellular carcinoma arising in hepatic adenoma: diagnostic and management implicationsDiagnostic Histopathology 2014; 20(6): 257 doi: 10.1016/j.mpdhp.2014.03.007
59
Joseph Misdraji, Barbara A. Centeno, Martha B. Pitman. Ancillary tests in the diagnosis of liver and pancreatic neoplasmsCancer Cytopathology 2018; 126(S8): 672 doi: 10.1002/cncy.22009
60
Venkata S. Katabathina, Christine O. Menias, Alampady K. P. Shanbhogue, Jaishree Jagirdar, Raj Mohan Paspulati, Srinivasa R. Prasad. Genetics and Imaging of Hepatocellular Adenomas: 2011 UpdateRadioGraphics 2011; 31(6): 1529 doi: 10.1148/rg.316115527
61
Taofic Mounajjed. Surgical Pathology of Liver Tumors2015; : 95 doi: 10.1007/978-3-319-16089-4_4
62
Mohammad Ali Husainy, Farhina Sayyed, Praveen Peddu. Typical and atypical benign liver lesions: A reviewClinical Imaging 2017; 44: 79 doi: 10.1016/j.clinimag.2017.05.002
63
Christian Grieser, Ingo G. Steffen, Incken-Birthe Kramme, Hendrik Bläker, Ergin Kilic, Carmen Maria Perez Fernandez, Daniel Seehofer, Eckart Schott, Bernd Hamm, Timm Denecke. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experienceEuropean Radiology 2014; 24(6): 1339 doi: 10.1007/s00330-014-3144-7
64
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2021; : 205 doi: 10.1016/B978-0-7020-7584-1.00011-5
65
Nancy M. Joseph, Annika Blank, Alan H. Shain, Ryan M. Gill, Sarah E. Umetsu, Nafis Shafizadeh, Michael S. Torbenson, Sanjay Kakar. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profilingHuman Pathology 2022; 122: 60 doi: 10.1016/j.humpath.2022.01.007
66
Hyunchul Kim, Ja-June Jang, Dong-Sik Kim, Beom Woo Yeom, Nam Hee Won. Clinicopathological Analysis of Hepatocellular Adenoma According to New Bordeaux Classification: Report of Eight Korean CasesKorean Journal of Pathology 2013; 47(5): 411 doi: 10.4132/KoreanJPathol.2013.47.5.411
67
Jean Charles Nault, Jessica Zucman Rossi. Molecular Classification of Hepatocellular AdenomasInternational Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/315947
68
Jason You, Hushan Yang, Yinzhi Lai, Lindsay Simon, Jen Au, Ashlie L. Burkart. AT-rich interactive domain 2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implicationsHuman Pathology 2015; 46(4): 583 doi: 10.1016/j.humpath.2015.01.001
69
Hervé Laumonier, Paulette Bioulac-Sage, Christophe Laurent, Jessica Zucman-Rossi, Charles Balabaud, Hervé Trillaud. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classificationHepatology 2008; 48(3): 808 doi: 10.1002/hep.22417
70
Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry2011; : 389 doi: 10.1007/978-1-4419-8062-5_23
71
Antje Schütt, Martin Zacharias, Nico Schneider, Silke Horn, Joachim Grötzinger, Stefan Rose-John, Dirk Schmidt-Arras. gp130 activation is regulated by D2–D3 interdomain connectivityBiochemical Journal 2013; 450(3): 487 doi: 10.1042/BJ20121660
72
Jing Han, Marius C. van den Heuvel, Hironori Kusano, Koert P. de Jong, Annette S. H. Gouw. How Normal Is the Liver in Which the Inflammatory Type Hepatocellular Adenoma Develops?International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/805621
73
Hisafumi KITAGAWA, Shouiti TSUDA, Kaori TUBOI, Ken YAGI, Akira YAMAMOTO, Tatsuhiko KITAMURA, Hideaki ENZAN, Makoto TOI. A Case of Well-differentiated Hepatocellular Carcinoma that Developed in a Normal Liver of a Young WomanNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2014; 75(1): 190 doi: 10.3919/jjsa.75.190
74
Vishal S Chandan, Sejal S Shah, Taofic Mounajjed, Michael S Torbenson, Tsung-Teh Wu. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenomaJournal of Clinical Pathology 2018; 71(6): 504 doi: 10.1136/jclinpath-2017-204820